Results of a recent research endeavor from the United States indicate that bromelain or bromelain rich pineapple stem may be utilized as an antiviral agent against coronavirus disease (COVID-19), but also for potential future coronavirus outbreaks. This exciting paper is currently available on the bioRxiv preprint server.
A novel method for 3D printing of milk-based products
Evidence-based approaches improve employment outcomes after spinal cord injury
New polygenic risk score to help predict the odds of drugs causing liver damage
Experimental set-up allows researchers to examine brain processes in birds during active tasks
U.S. adults experienced increased mental health issues as COVID-19 cases skyrocketed
Research provides deeper understanding of how neurons in the nose react to odors
Coronavirus: B Cells and T Cells
Breastfeeding and COVID-19
Coronavirus Incubation Period
SARS-CoV-2 Spike D614G Mutant is More Transmissible than Other Mutants
Is a Successful COVID-19 Candidate Vaccine to Market within One Year Feesible?
Verifying S Protein in a Trimeric Form
Pattern Formation and Cell Fate in Development
How is Trace Evidence Analyzed in Forensic Cases?
The Use of Nanosensors to Restore Retinal Vision
AI research using hastily gathered data for COVID-19 is a dangerous trend does not help patients or physicians and damages the AI community's reputation.
Mediastinal infections are primarily related to surgery, perforation of the esophagus and infectious spread from adjacent regions.
The process of organogenesis is the formation of organs during embryonic development. This article looks at the various organs formed.
Dr. Nicole Lieberman
News-Medical speaks to Dr. Nicole Lieberman about her latest research that discovered delayed immune responses may affect COVID-19 mortality rates.
Varun Kelkar, Dr. Charles Rolsky and Professor Rolf Halden
A team of researchers spoke to News-Medical about their latest research investigating whether micro and nanoplastics are accumulating in human tissues.
Dr. Brad L. Heckman
In this interview, Dr. Brad. L. Heckman speaks to News-Medical about a new pathway that could potentially treat Alzheimers disease.
Building a Successful Email Campaign for a Scientific Audience
Using Webinars to Tell Science Stories – PART II
Reaching Scientists Through Newsletters